Table 5.
Relationship between death among all participants and their characteristics and clinical and laboratory data.
Variable | Death |
χ2 | p-value | |
---|---|---|---|---|
Yes No. (%) | No No. (%) | |||
Age | 66.11 ± 14.86 | 63.35 ± 13.96 | 1.45 | 1.46 |
Sex | 0.001 | 0.969 | ||
Women | 25 (20.8) | 95 (79.2) | ||
Men | 50 (21) | 188 (79) | ||
Nationality | 0.6 | 0.437 | ||
Non-Saudi | 49 (22.3) | 171 (77.7) | ||
Saudi | 26 (18.8) | 112 (81.2) | ||
Duration of diabetes | 24.6 ± 9.39 | 16.3 ± 8.13 | 0.05 | 0.050 |
White blood cell count | 18.01 ± 10.64 | 16.55 ± 10.54 | 0.117 | 0.238 |
Hemoglobin | 9.04 ± 1.91 | 110.02 ± 2.59 | 2.81 | 0.005 |
HbA1C | 8.62 ± 2.107 | 9.458 ± 4.87 | 1.08 | 0.279 |
C-reactive protein | 156.11 ± 74.51 | 140.6 ± 93.59 | 0.93 | 0.353 |
Creatinine | 271.59 ± 236.42 | 156.81 ± 1 68.51 | 5.52 | <0.001 |
Chronic diseases | ||||
Cardiovascular disease | 36 (29.5) | 86 (70.5) | 8.18 | 0.004 |
Hypertension | 66 (24.3) | 206 (75.7) | 7.51 | 0.006 |
Chronic kidney disease | 26 (38.2) | 42 (61.8) | 15.14 | <0.001 |
An older age and ICU admission were the main risk factors for death (p < 0.05) (Table 6); the mortality rate was 0.2, and there were 75 deaths among the participants.